Related Experiment Video
Updated: Jul 30, 2025

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
Esophageal Ulcer After Intravitreal Ranibizumab Injection in a Patient With Age-Related Macular Degeneration
Xin Qing Li1,2, Ke Wei Zhu3,2, Jun Lai1
1Department of Pharmacy, Ganzhou People's hospital (The Affiliated Ganzhou Hospital of Nanchang University), Ganzhou 341000, Jiangxi Province, China.
Intravitreal ranibizumab injections for age-related macular degeneration (AMD) may be linked to esophageal ulcers. This case report highlights a potential side effect of ranibizumab, emphasizing the role of vascular endothelial growth factor-A (VEGF-A).
Area of Science:
- Ophthalmology
- Gastroenterology
- Pharmacology
Background:
- Ranibizumab is a monoclonal antibody fragment targeting vascular endothelial growth factor-A (VEGF-A).
- Age-related macular degeneration (AMD) is a common cause of vision loss in older adults.
- Intravitreal injections are a standard treatment for AMD.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

